120 related articles for article (PubMed ID: 38325708)
1. The bone morphogenetic protein 2 analogue L51P enhances spinal fusion in combination with BMP2 in an in vivo rat tail model.
Gantenbein B; Oswald KAC; Erbach GF; Croft AS; Bermudez-Lekerika P; Strunz F; Bigdon SF; Albers CE
Acta Biomater; 2024 Mar; 177():148-156. PubMed ID: 38325708
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates do not affect healing of a critical-size defect in estrogen-deficient mice.
Strunz F; Gentil-Perret S; Siegrist M; Bohner M; Saulacic N; Hofstetter W
Bone Rep; 2024 Mar; 20():101739. PubMed ID: 38304619
[TBL] [Abstract][Full Text] [Related]
3. The BMP2 antagonist inhibitor L51P enhances the osteogenic potential of BMP2 by simultaneous and delayed synergism.
Khattab HM; Ono M; Sonoyama W; Oida Y; Shinkawa S; Yoshioka Y; Maekawa K; Tabata Y; Sugama K; Sebald W; Kuboki T
Bone; 2014 Dec; 69():165-73. PubMed ID: 25240457
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates reduce biomaterial turnover in healing of critical-size rat femoral defects.
Hauser M; Siegrist M; Denzer A; Saulacic N; Grosjean J; Bohner M; Hofstetter W
J Orthop Surg (Hong Kong); 2018; 26(3):2309499018802487. PubMed ID: 30270749
[TBL] [Abstract][Full Text] [Related]
5. Fabrication of polycaprolactone-silanated β-tricalcium phosphate-heparan sulfate scaffolds for spinal fusion applications.
Bhakta G; Ekaputra AK; Rai B; Abbah SA; Tan TC; Le BQ; Chatterjea A; Hu T; Lin T; Arafat MT; van Wijnen AJ; Goh J; Nurcombe V; Bhakoo K; Birch W; Xu L; Gibson I; Wong HK; Cool SM
Spine J; 2018 May; 18(5):818-830. PubMed ID: 29269312
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow-derived mesenchymal stem cells assembled with low-dose BMP-2 in a three-dimensional hybrid construct enhances posterolateral spinal fusion in syngeneic rats.
Hu T; Abbah SA; Toh SY; Wang M; Lam RW; Naidu M; Bhakta G; Cool SM; Bhakoo K; Li J; Goh JC; Wong HK
Spine J; 2015 Dec; 15(12):2552-63. PubMed ID: 26342750
[TBL] [Abstract][Full Text] [Related]
7. L51P - A BMP2 variant with osteoinductive activity via inhibition of Noggin.
Albers CE; Hofstetter W; Sebald HJ; Sebald W; Siebenrock KA; Klenke FM
Bone; 2012 Sep; 51(3):401-6. PubMed ID: 22750402
[TBL] [Abstract][Full Text] [Related]
8. Effect of Oxy133, an osteogenic oxysterol, on new bone formation in rat two-level posterolateral fusion model.
Buser Z; Drapeau S; Stappenbeck F; Pereira RC; Parhami F; Wang JC
Eur Spine J; 2017 Nov; 26(11):2763-2772. PubMed ID: 28547574
[TBL] [Abstract][Full Text] [Related]
9. The local cytokine and growth factor response to recombinant human bone morphogenetic protein-2 (rhBMP-2) after spinal fusion.
Koerner JD; Markova DZ; Schroeder GD; Calio BP; Shah A; Brooks CW; Vaccaro AR; Anderson DG; Kepler CK
Spine J; 2018 Aug; 18(8):1424-1433. PubMed ID: 29550606
[TBL] [Abstract][Full Text] [Related]
10. The BMP2 variant L51P restores the osteogenic differentiation of human mesenchymal stromal cells in the presence of intervertebral disc cells.
Tekari A; May RD; Frauchiger DA; Chan SC; Benneker LM; Gantenbein B
Eur Cell Mater; 2017 Feb; 33():197-210. PubMed ID: 28266688
[TBL] [Abstract][Full Text] [Related]
11. Binding to COMP Reduces the BMP2 Dose for Spinal Fusion in a Rat Model.
Refaat M; Klineberg EO; Fong MC; Garcia TC; Leach JK; Haudenschild DR
Spine (Phila Pa 1976); 2016 Jul; 41(14):E829-E836. PubMed ID: 26679888
[TBL] [Abstract][Full Text] [Related]
12. Exogenous Stimulation of Human Intervertebral Disc Cells in 3-Dimensional Alginate Bead Culture With BMP2 and L51P: Cytocompatibility and Effects on Cell Phenotype.
May RD; Frauchiger DA; Albers CE; Hofstetter W; Gantenbein B
Neurospine; 2020 Mar; 17(1):77-87. PubMed ID: 32252157
[TBL] [Abstract][Full Text] [Related]
13. Creation and preclinical evaluation of a novel mussel-inspired, biomimetic, bioactive bone graft scaffold: direct comparison with Infuse bone graft using a rat model of spinal fusion.
Cottrill E; Pennington Z; Wolf MT; Dirckx N; Ehresman J; Perdomo-Pantoja A; Rajkovic C; Lin J; Maestas DR; Mageau A; Lambrechts D; Stewart V; Sciubba DM; Theodore N; Elisseeff JH; Witham T
J Neurosurg Spine; 2023 Jul; 39(1):113-121. PubMed ID: 37021767
[TBL] [Abstract][Full Text] [Related]
14. Preparation of Coralline Hydroxyapatite Implant with Recombinant Human Bone Morphogenetic Protein-2-Loaded Chitosan Nanospheres and Its Osteogenic Efficacy.
Xia YJ; Wang W; Xia H; Huang XH; Deng FP; Ying QS; Yu X; Li LH; Wang JH; Zhang Y
Orthop Surg; 2020 Dec; 12(6):1947-1953. PubMed ID: 33080108
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human bone morphogenic protein-2-enhanced anterior spine fusion without bone encroachment into the spinal canal: a histomorphometric study in a thoracoscopically instrumented porcine model.
Zhang H; Sucato DJ; Welch RD
Spine (Phila Pa 1976); 2005 Mar; 30(5):512-8. PubMed ID: 15738782
[TBL] [Abstract][Full Text] [Related]
16. Lower dose of rhBMP-2 achieves spine fusion when combined with an osteoconductive bulking agent in non-human primates.
Barnes B; Boden SD; Louis-Ugbo J; Tomak PR; Park JS; Park MS; Minamide A
Spine (Phila Pa 1976); 2005 May; 30(10):1127-33. PubMed ID: 15897825
[TBL] [Abstract][Full Text] [Related]
17. Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model.
Zhu W; Rawlins BA; Boachie-Adjei O; Myers ER; Arimizu J; Choi E; Lieberman JR; Crystal RG; Hidaka C
J Bone Miner Res; 2004 Dec; 19(12):2021-32. PubMed ID: 15537446
[TBL] [Abstract][Full Text] [Related]
18. Activin A and BMP chimera (AB204) induced bone fusion in osteoporotic spine using an ovariectomized rat model.
Son S; Yoon SH; Kim MH; Yun X
Spine J; 2020 May; 20(5):809-820. PubMed ID: 31899374
[TBL] [Abstract][Full Text] [Related]
19. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and beta-tricalcium phosphate in a rabbit model.
Namikawa T; Terai H; Suzuki E; Hoshino M; Toyoda H; Nakamura H; Miyamoto S; Takahashi N; Ninomiya T; Takaoka K
Spine (Phila Pa 1976); 2005 Aug; 30(15):1717-22. PubMed ID: 16094272
[TBL] [Abstract][Full Text] [Related]
20. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate.
Suh DY; Boden SD; Louis-Ugbo J; Mayr M; Murakami H; Kim HS; Minamide A; Hutton WC
Spine (Phila Pa 1976); 2002 Feb; 27(4):353-60. PubMed ID: 11840099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
